Penserra Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,780
| Closed | -$35K | – | 1638 |
|
|
2021
Q3 | $35K | Buy |
1,780
+30
| +2% | +$590 | ﹤0.01% | 1152 |
|
|
2021
Q2 | $65K | Buy |
1,750
+25
| +1% | +$929 | ﹤0.01% | 932 |
|
|
2021
Q1 | $44K | Buy |
1,725
+5
| +0.3% | +$128 | ﹤0.01% | 833 |
|
|
2020
Q4 | $37K | Buy |
1,720
+1,082
| +170% | +$23.3K | ﹤0.01% | 742 |
|
|
2020
Q3 | $11K | Buy |
+638
| New | +$11K | ﹤0.01% | 810 |
|